Abstract: Glycated haemoglobin (HbA1c) is a key marker in the management of diabetic patients, particularly for monitoring blood sugar balance. It is widely used for the diagnosis and management of diabetes. Given the low compliance with laboratory testing frequency and the subsequent delay in treatment modification, point-of-care (POC) HbA1c testing offers an opportunity to improve diabetes management through rapid, actionable test results that can be used to determine treatment effectiveness, make therapeutic adjustments, and ensure that patients are following recommendations. The objective of our study is to evaluate the concordance between point-of-care HbA1c results and laboratory-measured HbA1c values in a hospital-based diabetic population.
Niyogushima et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: